For small pharmas and biotechs approaching a commercial launch, agility and execution are more valuable than waiting for a ...

Professor Emeritus Herb Boyer's discovery of recombinant DNA changed medicine, ushering in a new era in biological treatments ...

The global white (industrial) biotechnology market is experiencing significant growth, driven by increasing demand for sustainable alternatives to traditional petroleum-based products. White ...

Puma Biotechnology, Inc. is a biopharmaceutical company with a focus on the development and commercialization of innovative products to enhance cancer care. Puma in-licensed the global development ...

Only five months after Galapagos announced it would split in two, the cell-therapy-focused biotech is already ... to hand back full development and commercialization rights to Galapagos’ pipeline.

"The collaborations involve the development of renewable energy and the commercialisation of sustainable biotechnology products, aligning with the aspirations of the National Biotechnology Policy ...

The index seeks to track the performance of the common stock of U.S. exchange-listed biotechnology companies with at least one drug therapy approved by the U.S. Food and Drug Administration ("FDA ...

Claritas aims to transform the diagnostics industry with powerful and effective software products created using image enhancement and AI technology enabling and assisting doctors and physicians to ...

With a focus on commercialization, Thurlow brings deep experience launching new products and technologies, creating customer partnerships, building teams and driving revenue growth. Throughout his ...

Sandra has overseen numerous initiatives within the commercialization space including ... development of future economic business models for pharmaceutical distribution, working closely with ...

Biotech success isn’t just about great ... This expert panel will explore how early commercialization planning, powered by real-world insights, can maximize an asset’s potential.